Free Trial

2seventy bio (TSVT) News Today

2seventy bio logo
$5.00 0.00 (0.00%)
As of 05/13/2025

TSVT Latest News

2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cash
2seventy bio (TSVT) Projected to Post Earnings on Tuesday
Get 2seventy bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter.

TSVT Media Mentions By Week

TSVT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TSVT
News Sentiment

0.00

0.90

Average
Medical
News Sentiment

TSVT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TSVT Articles
This Week

0

2

TSVT Articles
Average Week

Get 2seventy bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TSVT) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners